Brief: Pediapharm receives Health Canada approval for Rupatadine
July 21 (Reuters) - Pediapharm Inc:
* Pediapharm receives health Canada approval for Rupatadine
Source text for Eikon: urn:newsml:reuters.com:*:nCCN607qCp
Further company coverage: PDP.V
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million